Company intelligence / Profile preview

PAVmed

New York City, New York, United Statespavmed.com ↗

Ownership: Public · PAVM
Employees: ~107
Development stage: Commercial

Overview

PAVmed has commercialized multiple medical devices and diagnostics, notably the EsoGuard Esophageal DNA Test and EsoCheck Cell Collection Device through its subsidiary Lucid Diagnostics. These tools enable early detection of esophageal precancer. The company also markets CarpX for carpal tunnel syndrome and has a digital oncology remote monitoring solution via Veris Health. Recent financials show growing test volumes but ongoing operating losses as the company invests in commercialization.

Therapeutic areas: OtorhinolaryngologyOncologyCardiovascularNeurology
Modalities: DeviceDiagnostic testDigital health platform
Industry: Molecular Diagnostics

Partnerships

CancerX public-private partnership via Veris Health with Moffitt Cancer Center & Digital Medicine Societypartnership with VITALExam to enhance firefighter screening for esophageal precancer

Financials

Market cap: $28.9M
Total revenue: $33K
Enterprise value: $42.1M

Beyond the preview

Go deeper on PAVmed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PAVmed.

Explore the full profile